Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenstrom's Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study: Long Term Follow-up Results

被引：2

作者：

Cao, Xinxin ^{[1
]}

Jin, Jie ^{[2
]}

Cheng, Fu Cheng ^{[3
]}

Yi, Shuhua ^{[4
]}

Zhao, Weili ^{[5
]}

Sun, Zimin ^{[6
]}

Yang, Wei ^{[7
]}

Li, Dengju ^{[8
]}

Cui, Guohui ^{[9
]}

Hu, Jianda ^{[10
]}

Liu, Ting ^{[11
,12
]}

Song, Yongping ^{[13
]}

Xu, Bing ^{[14
]}

Zhu, Zunmin ^{[15
]}

Xu, Wei ^{[16
]}

Zhang, Mingzhi ^{[17
,18
]}

Li, Sichen ^{[19
]}

Wang, Weige ^{[20
]}

Zhao, Renbin ^{[19
]}

Zhou, Daobin ^{[21
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Hematol, Peking Union Med Coll Hosp, Beijing, Peoples R China

[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China

[3] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China

[4] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,Inst Hematol & Blood Dis H, Tianjin, Peoples R China

[5] Shanghai Jiao Tong Univ, Natl Res Ctr Translat Med, Shanghai Rui Jin Hosp,Shanghai Inst Hematol, State Key Lab Med Genom,Sch Med, Shanghai, Peoples R China

[6] Anhui Prov Hosp, Hefei, Peoples R China

[7] China Med Univ, Dept Hematol, Shengjing Hosp, Shenyang, Peoples R China

[8] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Hematol, Tongji Hosp, Wuhan, Peoples R China

[9] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China

[10] Fujian Med Univ, Dept Hematol, Affiliated Hosp 2, Fuzhou, Peoples R China

[11] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Peoples R China

[12] Sichuan Univ, West China Hosp, Inst Hematol, Chengdu, Peoples R China

[13] Zhengzhou Univ, Henan Canc Hosp, Dept Hematol, Affiliated Canc Hosp, Zhengzhou, Peoples R China

[14] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China

[15] Henan Prov Peoples Hosp, Zhengzhou, Peoples R China

[16] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, Nanjing, Peoples R China

[17] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China

[18] Lymphoma Diag & Treatment Ctr Henan Prov, Zhengzhou, Peoples R China

[19] InnoCare Pharma Ltd, Beijing, Peoples R China

[20] InnoCare Pharma Ltd, Shanghai, Peoples R China

[21] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-181500

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenstrom's macroglobulinemia
Sekiguchi, Naohiro
Rai, Shinya
Munakata, Wataru
Suzuki, Kenshi
Handa, Hiroshi
Shibayama, Hirohiko
Endo, Tomoyuki
Terui, Yasuhito
Iwaki, Noriko
Fukuhara, Noriko
Tatetsu, Hiro
Iida, Shinsuke
Ishikawa, Takayuki
Shiibashi, Ryota
Izutsu, Koji
[J]. CANCER SCIENCE, 2020, 111 (09) : 3327 - 3337
[42] Results of PX-171-003-A0, part 1 of an open-label, single-arm, phase 2 study of carfilzomib in patients with relapsed and refractory multiple myeloma
Siegel, D.
Vij, R.
Stewart, K.
Somlo, G.
Jakubowiak, A.
Kukreti, V.
Bahlis, N.
Singhal, S.
Wong, A.
Jagannath, S.
[J]. EJC SUPPLEMENTS, 2009, 7 (02): : 571 - 571
[43] Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study
Ma, Xinran
Li, Ling
Zhang, Lei
Fu, Xiaorui
Li, Xin
Wang, Xinhua
Wu, Jingjing
Sun, Zhenchang
Zhang, Xudong
Feng, Xiaoyan
Chang, Yu
Zhou, Zhiyuan
Nan, Feifei
Zhang, Jieming
Li, Zhaoming
Zhang, Mingzhi
[J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 275 - 284
[44] Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patients
Kurihara, Yuichi
Yamagami, Jun
Funakoshi, Takeru
Ishii, Maki
Miyamoto, Julia
Fujio, Yumi
Kakuta, Risa
Tanikawa, Akiko
Aoyama, Yumi
Iwatsuki, Keiji
Ishii, Norito
Hashimoto, Takashi
Nishie, Wataru
Shimizu, Hiroshi
Kouyama, Keisuke
Amagai, Masayuki
[J]. JOURNAL OF DERMATOLOGY, 2019, 46 (02): : 124 - 130
[45] SINGLE-AGENT IBRUTINIB IN RITUXIMAB-REFRACTORY PATIENTS WITH WALDENSTROM'S MACROGLOBULINEMIA (WM): UPDATED RESULTS FROM A MULTICENTER, OPEN-LABEL PHASE 3 SUBSTUDY (INNOVATETM)
Dimopoulos, M.
Trotman, J.
Tedeschi, A.
Matous, J. V.
Macdonald, D.
Tam, C.
Tournilhac, O.
Ma, S.
Oriol, A.
Heffner, L.
Shustik, C.
Garcia-Sanz, R.
Cornell, R. F.
Fernandez de Larrea, C.
Castillo, J. J.
Granell, M.
Kyrtsonis, M. C.
Leblond, V.
Symeonidis, A.
Singh, P.
Li, J.
Graef, T.
Bilotti, E.
Treon, S.
Buske, C.
[J]. HAEMATOLOGICA, 2016, 101 : 256 - 257
[46] LONG-TERM FOLLOW-UP IN PX-171-003-A1, AN OPEN-LABEL, SINGLE-ARM PHASE (PH) 2 STUDY OF CARFILZOMIB (CFZ) IN PATIENTS (PTS) WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (R/R MM): ANALYSIS BY SUBGROUPS OF INTEREST
Siegel, D. S.
Martin, T.
Wang, M.
Vij, R.
Jakubowiak, A. J.
Lonial, S.
Kukreti, V.
Alsina, M.
Somlo, G.
Kunkel, L.
Wong, A.
Orlowski, R. Z.
Stewart, A. K.
Singhal, S.
Jagannath, S.
[J]. ANNALS OF ONCOLOGY, 2011, 22 : 200 - 200
[47] Long-Term Follow-up of Idelalisib Monotherapy in Patients with Double-Refractory Marginal Zone Lymphoma or Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia
Wagner-Johnston, Nina D.
Schuster, Stephen J.
de Vos, Sven
Salles, Gilles A.
Jurczak, Wojciech
Rajakumaraswamy, Nishan
Xing, Guan
Gopal, Ajay K.
[J]. BLOOD, 2019, 134
[48] Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study
Neutel, Joel M.
Giles, Thomas D.
Punzi, Henry
Weiss, Robert J.
Li, Huiling
Finck, Amy
[J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (12) : 915 - 920
[49] Ibrutinib Efficacy, Safety, and Pharmacokinetics in Chinese Patients with Relapsed or Refractory Waldenström's Macroglobulinemia: A Multicenter, Single-Arm, Phase 4 Study
Yi, Shuhua
Cai, Zhen
Hu, Yu
He, Aili
Gao, Sujun
Li, Qian
Sha, Linlin
Zhang, Nating
Ren, Yupeng
Gai, Xue
Yang, Xue
Qin, Rui
Qiu, Lugui
[J]. ADVANCES IN THERAPY, 2024, 41 (02) : 672 - 685
[50] Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of Panobinostat in Combination with Bortezomib and Dexamethasone in Japanese Patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma
Suzuki, Kenshi
Sunami, Kazutaka
Matsumoto, Morio
Maki, Akio
Shimada, Fumika
Suzuki, Kazuyuki
Shimizu, Kazuyuki
[J]. ACTA HAEMATOLOGICA, 2021, 144 (03) : 264 - 274

← 1 2 3 4 5 →